Short Interest in TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Declines By 37.5%

Retrieved on: 2021-03-15 08:48:45

Tags for this article:

Click the tags to see associated articles and topics

Short Interest in TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Declines By 37.5%. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 169,100 shares of the biopharmaceutical company's stock valued at $1,978,000 after buying an additional ...

Article found on: www.marketbeat.com